Evaluation for neurotoxicity of oxaliplatin using Nerve Conduction Velocity

Evaluation for neurotoxicity of oxaliplatin using Nerve Conduction Velocity - NEO-NCV study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004305

Enrollment

Registered

2010-09-30

Start date

2008-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

1.Nerve Conduction Velocity 2.tuning fork

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically confirmed colorectal cancer 2) No prior L-OHP administration 3) No peripheral neuropathy 4) Voluntary written informed consent

Exclusion criteria

Exclusion criteria: Metastasis to the CNS

Design outcomes

Primary

Measure	Time frame
1. Collation between NCV and oxaliplatin induced neurotoxicity 2. Collation between tuning fork and oxaliplatin induced neurotoxicity 3. Analyze the mechanism of oxaliplatin induced neurotoxicity	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026